Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency

Louis J. Muglia, Lauren Jacobson, Christina Luedke, Sherri K. Vogt, Michele Schaefer, Pieter Dikkes, Shoko Fukuda, Yoko Sakai, Toshihiro Suda, Joseph A. Majzoub

Research output: Contribution to journalArticle

Abstract

Corticotropin-releasing hormone (CRH)-deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic- pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.

Original languageEnglish (US)
Pages (from-to)1269-1277
Number of pages9
JournalJournal of Clinical Investigation
Volume105
Issue number9
StatePublished - May 2000
Externally publishedYes

Fingerprint

Adrenal Insufficiency
Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Glucocorticoids
Gene Expression
Pro-Opiomelanocortin
Adrenalectomy
Messenger RNA
Hypopituitarism
Aldosterone
Peptides

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Muglia, L. J., Jacobson, L., Luedke, C., Vogt, S. K., Schaefer, M., Dikkes, P., ... Majzoub, J. A. (2000). Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. Journal of Clinical Investigation, 105(9), 1269-1277.

Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. / Muglia, Louis J.; Jacobson, Lauren; Luedke, Christina; Vogt, Sherri K.; Schaefer, Michele; Dikkes, Pieter; Fukuda, Shoko; Sakai, Yoko; Suda, Toshihiro; Majzoub, Joseph A.

In: Journal of Clinical Investigation, Vol. 105, No. 9, 05.2000, p. 1269-1277.

Research output: Contribution to journalArticle

Muglia, LJ, Jacobson, L, Luedke, C, Vogt, SK, Schaefer, M, Dikkes, P, Fukuda, S, Sakai, Y, Suda, T & Majzoub, JA 2000, 'Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency', Journal of Clinical Investigation, vol. 105, no. 9, pp. 1269-1277.
Muglia, Louis J. ; Jacobson, Lauren ; Luedke, Christina ; Vogt, Sherri K. ; Schaefer, Michele ; Dikkes, Pieter ; Fukuda, Shoko ; Sakai, Yoko ; Suda, Toshihiro ; Majzoub, Joseph A. / Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. In: Journal of Clinical Investigation. 2000 ; Vol. 105, No. 9. pp. 1269-1277.
@article{856ff236bad644e6a3c64a85ac53e1e8,
title = "Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency",
abstract = "Corticotropin-releasing hormone (CRH)-deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic- pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.",
author = "Muglia, {Louis J.} and Lauren Jacobson and Christina Luedke and Vogt, {Sherri K.} and Michele Schaefer and Pieter Dikkes and Shoko Fukuda and Yoko Sakai and Toshihiro Suda and Majzoub, {Joseph A.}",
year = "2000",
month = "5",
language = "English (US)",
volume = "105",
pages = "1269--1277",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "9",

}

TY - JOUR

T1 - Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency

AU - Muglia, Louis J.

AU - Jacobson, Lauren

AU - Luedke, Christina

AU - Vogt, Sherri K.

AU - Schaefer, Michele

AU - Dikkes, Pieter

AU - Fukuda, Shoko

AU - Sakai, Yoko

AU - Suda, Toshihiro

AU - Majzoub, Joseph A.

PY - 2000/5

Y1 - 2000/5

N2 - Corticotropin-releasing hormone (CRH)-deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic- pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.

AB - Corticotropin-releasing hormone (CRH)-deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic- pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.

UR - http://www.scopus.com/inward/record.url?scp=12944317210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944317210&partnerID=8YFLogxK

M3 - Article

C2 - 10792002

AN - SCOPUS:12944317210

VL - 105

SP - 1269

EP - 1277

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 9

ER -